Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments.
- DOI
- 10.1200/jco-26-00785
- Published
- 2026 Sep 15
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco-26-00785,
title = {Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments.},
author = {Mitchell AP and Winn AN and Augello P and Gallagher G and Mishra Meza A and Abdelaziz A and Guzman G and Galanter N and Chakraborty N and Klimchuk M and Alsamarai S and Rajkumar SV and Bach PB and Gönen M and Dusetzina SB},
year = {2026},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco-26-00785},
url = {https://doi.org/10.1200/jco-26-00785}
}RIS
TY - JOUR TI - Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments. AU - Mitchell AP AU - Winn AN AU - Augello P AU - Gallagher G AU - Mishra Meza A AU - Abdelaziz A AU - Guzman G AU - Galanter N AU - Chakraborty N AU - Klimchuk M AU - Alsamarai S AU - Rajkumar SV AU - Bach PB AU - Gönen M AU - Dusetzina SB PY - 2026 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco-26-00785 UR - https://doi.org/10.1200/jco-26-00785 ER -
APA
AP, M., AN, W., P, A., G, G., A, M. M., A, A., G, G., N, G., N, C., M, K., S, A., SV, R., PB, B., M, G., & SB, D. (2026). Financial Payments From Drug Manufacturers to Oncologists and Use of Guideline-Preferred Cancer Treatments.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-26-00785
Source records
- pubmed · retrieved 2026-09-25T16:48:16.129Z